Skip to main content
Premium Trial:

Request an Annual Quote

UK's Babraham Institute Opens New Bioincubator Building, Expanding Space for Startups

By Alex Philippidis

NEW YORK (GenomeWeb News) – The commercial arm of the UK's Babraham Institute has expanded its bioincubator space by 8,000 square feet following the opening of its £4 million ($6.4 million) Maia building within its campus.

Babraham Bioscience Technologies Ltd. has attracted seven companies to the space, spokeswoman Claire Cockcroft told GenomeWeb Daily News. Synome, Recombinant Antibody Technology, and Convergence Pharmaceuticals are new arrivals to the Babraham Research Campus located some 6 miles south of Cambridge, let alone Maia. Another four other companies have relocated to Maia from smaller spaces within the campus — Innova Biosciences, Total Scientific, Urosens, and Alpha Biologics.

Those companies, and future tenant businesses at Maia, will have access to the Technology Development Laboratory, a biology and chemistry laboratory designed for proof-of-concept stage users in molecular biology, protein biochemistry, cell biology, and medicinal and synthetic chemistry.

The new space, as with current incubator space, will be open to startups whether spun out of the institute or from elsewhere.

With the opening of Maia, the campus now has about 70,000 square feet of total bioincubator space for startups.

The new building was originally planned as the first of two "Maia" phases; Cockcroft had no information on the status of the second phase.

A ceremony marking the completion of Maia was held last week, following the delivery of the 2010 Bioenterprise Lecture by Sir Gregory Winter.

Funding for the Maia building came from the Biotechnology and Biological Sciences Research Council, which supports the Babraham Institute.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.